Is Regulus Therapeutics Inc (NASDAQ: RGLS) Proving The Doubters Wrong?
Regulus Therapeutics Inc (RGLS) concluded trading on Wednesday at a closing price of $7.98, with 28.53 million shares of worth about $227.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 454.17% during that period and on April 30, 2025 the price saw a […]
